Location History:
- Fairfield, CT (US) (1997 - 2003)
- Leeds, GB (2002 - 2006)
Company Filing History:
9 out of 1,345 
1 out of 832,880 Years Active: 1997-2006
Title: The Innovative Contributions of Pamela F. Jones
Introduction
Pamela F. Jones is a prominent inventor based in Leeds, GB. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions related to TIE-2 ligands. With a total of 10 patents to her name, her work has had a substantial impact on medical research and treatment methodologies.
Latest Patents
Among her latest patents, Pamela has developed innovative methods involving TIE-2 ligands. One notable invention provides an isolated nucleic acid molecule encoding a human TIE-2 ligand. This invention includes a receptor body that specifically binds to the human TIE-2 ligand, as well as an antibody that targets this ligand. Additionally, her work encompasses therapeutic compositions and methods aimed at blocking blood vessel growth, promoting neovascularization, and preventing tumor growth in humans. Another significant patent focuses on TIE ligand-4, which also includes isolated nucleic acid molecules and therapeutic applications similar to her previous inventions.
Career Highlights
Pamela has worked with notable companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. Her career is marked by a commitment to advancing medical science through her innovative inventions and research.
Collaborations
Throughout her career, Pamela has collaborated with esteemed colleagues such as George D. Yancopoulos and Samuel H. Davis. These partnerships have further enhanced her contributions to the field.
Conclusion
Pamela F. Jones stands out as a leading inventor in biotechnology, with her work on TIE-2 ligands paving the way for new therapeutic approaches. Her numerous patents and collaborations reflect her dedication to innovation and medical advancement.